Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial

Leukemia. 2023 Nov;37(11):2276-2281. doi: 10.1038/s41375-023-02034-4. Epub 2023 Sep 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Gene Rearrangement
  • Humans
  • Infant
  • Myeloid-Lymphoid Leukemia Protein / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Tretinoin / therapeutic use

Substances

  • Myeloid-Lymphoid Leukemia Protein
  • Tretinoin